Diclofenac Sodium 1.5% Solution
Product Images NDC 70512-038

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium 1.5% (NDC 70512-038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sola Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (267405 Diclofenac Sodium 150ml Label Final Copy 2)

Diclofenac Sodium Topical Solution USP 1.5% w/w in a 5 fl. oz. (150 mL) bottle, labeled for prescription use. The label states the active ingredient is diclofenac sodium 16.05 mg/mL in a solution form, provides directions for use, external use only warnings, and manufacturer information for SOLA Pharmaceuticals. The label includes dosage instructions, storage conditions, and package barcode.*

FDA Label Image

Carton (267406 Diclofenac Sodium 150ml Carton Final Copy 2)

Packaging label for Diclofenac Sodium Topical Solution USP 1.5% w/w, labeled as 16.05 mg/mL strength. The label indicates a 5 fl. oz. (150 mL) container from SOLA Pharmaceuticals. It includes directions for external use only, a note to pharmacists to dispense the Medication Guide separately, and standard drug information and warnings. The label also displays the NDC number 70512-038-05 and features the SOLA Pharmaceuticals logo.*

FDA Label Image

Eff 2 (Efficacy 2 Copy)

A data table presenting efficacy variables from Study II, comparing mean baseline scores and mean changes after 12 weeks of treatment between Diclofenac Sodium Topical Solution and a topical vehicle. Variables include WOMAC pain score, WOMAC physical function, and PGA score, with values shown for each treatment group and baseline measurements.*

FDA Label Image

Efficacy (Efficacy Variable Copy)

A data table titled 'Study I' presenting mean baseline scores and mean changes in efficacy variables after 12 weeks of treatment. It compares Diclofenac Sodium Topical Solution (N=154), topical placebo (N=155), and topical vehicle (N=161) across variables including WOMAC pain score, WOMAC physical function, and POHA, with notes on placebo and vehicle formulations containing DMSO.*

FDA Label Image

Figure A (Figure A Copy)

An instructional illustration labeled Figure A showing two ways to apply a topical solution. The first depicts one hand pouring solution onto the open palm of the other hand, and the second shows the solution being dispensed directly onto the skin, likely for application to an arm.*

FDA Label Image

Figure B (Figure B C Copy)

Instructional illustrations showing how to apply Diclofenac Sodium 1.5% topical solution. Figure B depicts a hand applying the solution on the knee using a downward motion, while Figure C shows a hand applying the solution on a different part of the leg using a circular motion.*

FDA Label Image

Molecule (Molecule Copy)

Chemical structure of Diclofenac Sodium displaying two chlorinated aromatic rings, an amine group, and a carboxylate sodium group characteristic of the compound's molecular arrangement.*

FDA Label Image

Pharmacokinetic (Pharmacokinetic Parameters Copy)

A data table presenting pharmacokinetic parameters for Diclofenac Sodium in normal adults aged 18 to 55 years. It compares values for single and multiple dosing regimens, including AUC0-∞, plasma Cmax, Tmax, and related clearance and elimination constants.*

FDA Label Image

Treatment (Treatment Group Copy)

A data table comparing adverse reactions between patients treated with Diclofenac Sodium Topical Solution 1.5% and a topical placebo. It lists various adverse reactions, including dry skin, contact dermatitis, dyspepsia, abdominal pain, pruritus, diarrhea, and others, showing the number and percentage of occurrences in each treatment group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.